Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies |
B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL) | Phase1 | Belgium China France Israel Italy Japan Singapore Spain United States View all |
A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer |
Breast Cancer | Jordan Oman Saudi Arabia United Arab Emirates View all |
|
Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI) |
Acute Kidney Injury Due to Sepsis | Phase2 | Argentina Australia Austria Belgium Brazil Canada China France Germany Hungary India Italy Japan South Africa Spain Thailand United Kingdom United States View all |
Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors |
Polycythemia Vera | Phase4 | Germany |
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis |
Scleroderma, Diffuse | Phase2 | Australia Denmark France Germany Israel Italy Japan Netherlands Singapore Spain Switzerland Taiwan United States View all |
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG. |
Generalized Myasthenia Gravis | Phase3 | China Greece Israel Italy Japan Poland Portugal Spain United Kingdom United States View all |
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V |
Lupus Nephritis | Phase2 | Argentina Brazil China Colombia France Germany Hong Kong Hungary India Israel Malaysia Mexico Philippines Portugal Puerto Rico Singapore Spain Turkey (Türkiye) United Kingdom United States View all |
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors |
Solid Tumor | Phase1, Phase2 | Australia Canada United States |
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. |
MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers | Phase1 | Belgium China France Germany Israel Italy Japan Norway Singapore South Korea Spain Sweden Taiwan United Kingdom United States View all |
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). |
Systemic Lupus Erythematosus | Phase3 | Argentina Australia Brazil Bulgaria Canada Chile China Colombia Czechia France Germany Guatemala Hungary India Italy Japan Malaysia Mexico Poland Portugal Romania South Korea Spain Taiwan Thailand United States View all |